J Clin Oncol 31 (17): 2128-35, 2013.[PUBMED Abstract] Connolly RM, Zhao F, Miller KD, et al.: E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer.
A Trial of the ECOG-ACRIN Cancer Research Group.
J Clin Oncol 39 (28): 3171-3181, 2021.[PUBMED Abstract] Bonneterre J, Th√ºrlimann B, Robertson JF, et al.: Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.
J Clin Oncol 18 (22): 3748-57, 2000.[PUBMED Abstract] Nabholtz JM, Buzdar A, Pollak M, et al.: Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial.